ArticleJAAD international2026
Phenotypic characterization of neurofibromatosis type 1 in a large Chinese cohort: A cross-sectional study.
Article in JAAD international, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Practical guideline for malignant peripheral nerve sheath tumors.Innovation (Cambridge (Mass.)) · 2026Article
- Sturge-Weber syndrome type III in pediatrics: a case report.Frontiers in radiology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Neurofibromatosis type 1 (NF1) is a multisystemic genetic disorder characterized by Objective: To evaluate the phenotypic characteristics of Chinese patients with NF1. Methods: This cross-sectional, multicenter study involved patients with NF1 from Chinese and U.S. populations. Clinical data were obtained from NF1 clinics and patient-reported outcome assessments. Findings: 1313 patients with Chinese NF1 were included. We found that Chinese patients were diagnosed later in life and exhibited a lower prevalence of spinal neurofibromas and fractures but a higher rate of malignant peripheral nerve sheath tumors as compared to U.S. patients. Four distinct NF1 subtypes were identified: severe neural, cutaneous, hereditary, and mild. Significant correlations were observed between freckles and cutaneous neurofibromas and between bone lesions and pseudarthrosis. Cutaneous manifestations were correlated with systemic manifestations, and the risk of developing plexiform neurofibromas was inversely proportional to the number of cutaneous neurofibromas and freckles. Limitations: The use of self-report data may introduce subjectivity and recall bias. Conclusion: This study provides the first comprehensive analysis of clinical phenotypes in Chinese patients with NF1. The identification of distinct NF1 subtypes, phenotypic correlations, and ethnic differences supports more personalized management strategies for NF1 patients.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.